Controlling Hypertension After Severe Cerebrovascular Event

NCT02982655 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2019-04-02

No results posted yet for this study

Summary

The purpose of this academic lead study is to explore ideal blood pressure targets and optimum individualized anti-hypertension strategies in acute severe stroke.

Conditions

Interventions

PROCEDURE

Individualized BP lowering

Sponsors & Collaborators

  • Tang-Du Hospital

    collaborator OTHER
  • Xi'an Central Hospital

    collaborator OTHER
  • Shaanxi Provincial People's Hospital

    collaborator OTHER
  • Hanzhong Central Hospital

    collaborator OTHER
  • Yan'an University Affiliated Hospital

    collaborator OTHER
  • Xiangyang Central Hospital

    collaborator OTHER
  • Xi'an 141 Hospital

    collaborator UNKNOWN
  • Shangluo Central Hospital

    collaborator OTHER
  • 215 Hospital of Shaanxi NI

    collaborator OTHER
  • Yulin No.2 Hospital

    collaborator OTHER
  • Yulin No.1 Hospital

    collaborator UNKNOWN
  • Ankang Central Hospital

    collaborator OTHER
  • First Affiliated Hospital Xi'an Jiaotong University

    collaborator OTHER
  • Xi'an Gaoxin Hospital

    collaborator OTHER
  • 521 Hospital of NORINCO Group

    collaborator OTHER
  • Xi'an No.3 Hospital

    collaborator OTHER_GOV
  • Xi'an No.4 Hospital

    collaborator UNKNOWN
  • Xi'an No.9 Hospital

    collaborator UNKNOWN
  • Xi'an XD Group Hospital

    collaborator UNKNOWN
  • Xi'an Traditional Chinese Medicine Hospital

    collaborator OTHER
  • Baoji Central Hospital

    collaborator OTHER
  • Weinan Central Hospital

    collaborator OTHER
  • Tongchuan Mining Hospital

    collaborator UNKNOWN
  • Tongchuan People's Hospital

    collaborator UNKNOWN
  • Xijing Hospital

    lead OTHER

Principal Investigators

  • Wen Jiang, PhD · Department of Neurology, Xijing Hospital, Fourth Military Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2018-11-30
Completion
2018-11-30

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02982655 on ClinicalTrials.gov